Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.

Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.

Ude M Schüssel K Quinzler R Leuner K Müller WE Schulz M

J Hypertens. 2011 Sep; 29(9): 1837-45.
doi: 10.1097/HJH.0b013e32834942be

https://journals.lww.com/jhypertension/Abstract/2011/09000/Generic_switch_after_ramipril_patent_expiry_is_not.23.aspx

Conflicts of interests: none declared.